KRRO is in the biotechnology space in the gene-editing realm. It is in portfolios of C. Woods . A recent analyst gave it an upside to 100 which is very favorable given its product line and track record with an all-time high of about $250 ( which is about 450% over current valuation) On the one-hour time frame, it has had a great week and is breaking out over...
HRTX has been suggested by various trading websites as a potentially explosive penny biotech stock for 2024. It has experienced excellent price actions since an earnings beat in November. It beat the estimates; that is to say it burned about half as much cash as the analysts estimated the it would. Today it pumped 11%. Relevant articles can be found compiled...
Can see this at $15.00 given that is where most shares are currently held, according to FRVP; this means there will likely be little downwards price pressure until then. Biotech is generally bearish outside of select, short-lived bull runs - this, in my opinion, creates an opportunity for sentiment arbitrage and is my reasoning for the trade (short term/long term...
XBI - long term profit ? A famous index, descending trendline break out, above the 150 moving average line, high volume. Only an idea and not a recommendation for trading!
Comments: This started out as an October 20th 76 short put (See Post Below) and then proceeded to crater quite massively, resulting in early, random assignment of shares. In an attempt to get my cost basis immediately within earshot of where the underlying is currently trading, I went extremely long-dated and sold the Jan '25 77 for 7.05 against my one lot,...
I multiplied the less risky Dow and Spy while dividing it with a multiple of bio, the Russel and Ark. This shows a clear shooting star candle in development this month which should signal much greater future gains in higher risk stocks and an end to this pullback in the market. You can see that we had nice rallies the last two times that this has happened on...
... for a .65 credit. Comments: Originally opened this for .77 (See Post Below); rolling down and out for a .65 credit. Total credits collected of 1.42. I may still get assigned, but at a slightly better price than were I to just have left it alone.
... for a .70 credit. Comments: Targeting the <16 delta strike paying around 1% of the strike price in credit. Basically, just building a position here on this weakness.
... for a .61 credit. Comments: Adding a rung to beaten-down biotech at strikes better than what I currently have on in October at the 76, November at the 71, and December at the 63, targeting the <16 delta strike paying around 1% of the strike price in credit. I'll be assigned shares on the 76 here shortly (and possibly the 71), after which I'll proceed to...
Comments: Adding a couple rungs to my XBI position at strikes better than what I currently have on, targeting the <16 delta strike paying around 1% of the strike price in credit. December 15th 47: .62 credit February 16th 50: .57 credit I would've also gone with January, but already have a rung on at where I'd want to pitch my tent.
Comments: Looking to sell the around the 30 delta here in the October monthly, which is more aggressive than I usually go, but am fine with taking assignment, selling call against if it comes to that. Currently, the strike is bid 1.45/ask 1.65 with a 1.55 mid, so will look to get a fill "in that neighborhood." Just looking for some "engagement" in this broad...
... for a .77 credit. Comments: Targeting the shortest duration <16 delta short puts paying around 1% of the strike price in credit to emulate dollar cost averaging into the biotech exchange-traded fund.
... for an .82/contract credit. Comments: Targeting the <16 delta strike paying around 1% of the strike price in credit to emulate dollar cost averaging into the biotech sector. I'm fine with getting assigned, selling call against, but mainly just selling premium in some relatively high IV sector exchange-traded funds (XBI's at 30.9%) while I wait for some of...
- XBI IWM ARKK FXI these sectors may play lagger bull catch up soon if market continues to run - PYPL BABA and other growth stock names may as well.
On 4/11/23 our Algo alert software had a buy signal, today there is a really nice bull flag forming on the AMEX:XBI ETF Biotechnology sector
Destination is 94 First obstacle is 90 area stop should be at 84+-
Biotech stocks have been my focus as many are showing significant relative strength and posting new 52 week highs. I got long XBI yesterday on the break of $85. Something to consider - stocks well below their all-time highs have a lot of supply to contend with, so the probability of a smooth trend out of a base tends to be lower and raises the probability of...
labu just completed a breakout from the abcd pattern and im anticipating a bull flag breakout to 13, then 19, in which I then see a retrace to form the handle to the base of the cup